EWTX logo

Edgewise Therapeutics, Inc. (EWTX) Cash From Investing

Annual CFI:

-$184.66M-$287.54M(-279.48%)
December 31, 2024

Summary

  • As of today, EWTX annual cash from investing is -$184.66 million, with the most recent change of -$287.54 million (-279.48%) on December 31, 2024.
  • During the last 3 years, EWTX annual cash from investing has risen by +$57.57 million (+23.77%).
  • EWTX annual cash from investing is now -279.48% below its all-time high of $102.89 million, reached on December 31, 2023.

Performance

EWTX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXcash flow metrics

Quarterly CFI:

-$162.17M-$206.06M(-469.42%)
June 30, 2025

Summary

  • As of today, EWTX quarterly cash from investing is -$162.17 million, with the most recent change of -$206.06 million (-469.42%) on June 30, 2025.
  • Over the past year, EWTX quarterly cash from investing has dropped by -$199.53 million (-533.97%).
  • EWTX quarterly cash from investing is now -430.67% below its all-time high of $49.04 million, reached on March 31, 2023.

Performance

EWTX Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXcash flow metrics

TTM CFI:

-$71.98M-$199.53M(-156.44%)
June 30, 2025

Summary

  • As of today, EWTX TTM cash from investing is -$71.98 million, with the most recent change of -$199.53 million (-156.44%) on June 30, 2025.
  • Over the past year, EWTX TTM cash from investing has increased by +$108.55 million (+60.13%).
  • EWTX TTM cash from investing is now -156.44% below its all-time high of $127.55 million, reached on March 31, 2025.

Performance

EWTX TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEWTXcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

EWTX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-279.5%-534.0%+60.1%
3Y3 Years+23.8%-10000.0%-619.6%
5Y5 Years-10000.0%-10000.0%-10000.0%

EWTX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-279.5%+23.8%-430.7%+39.6%-156.4%+66.4%
5Y5-Year-279.5%+23.8%-430.7%+39.6%-156.4%+74.3%
All-TimeAll-Time-279.5%+23.8%-430.7%+39.6%-156.4%+74.3%

EWTX Cash From Investing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$162.17M(-469.4%)
-$71.98M(-156.4%)
Mar 2025
-
$43.90M(+109.8%)
$127.55M(+169.1%)
Dec 2024
-$184.66M(-279.5%)
$20.92M(-17.5%)
-$184.66M(-3.4%)
Sep 2024
-
$25.36M(-32.1%)
-$178.59M(+1.1%)
Jun 2024
-
$37.37M(+113.9%)
-$180.54M(+15.8%)
Mar 2024
-
-$268.31M(-1094.4%)
-$214.46M(-308.4%)
Dec 2023
$102.89M(+245.8%)
$26.98M(+15.2%)
$102.89M(>+9900.0%)
Sep 2023
-
$23.42M(+580.4%)
$307.00K(+100.6%)
Jun 2023
-
$3.44M(-93.0%)
-$49.43M(+6.6%)
Mar 2023
-
$49.04M(+164.9%)
-$52.92M(+25.0%)
Dec 2022
-$70.58M
-$75.60M(-187.2%)
-$70.58M(-468.7%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$26.32M(>-9900.0%)
$19.14M(+38.2%)
Jun 2022
-
-$46.00K(-100.1%)
$13.85M(+109.5%)
Mar 2022
-
$31.39M(+122.3%)
-$146.07M(+39.7%)
Dec 2021
-$242.23M(-893.5%)
$14.12M(+144.7%)
-$242.23M(+13.7%)
Sep 2021
-
-$31.61M(+80.2%)
-$280.53M(-12.7%)
Jun 2021
-
-$159.97M(-147.0%)
-$248.92M(-179.2%)
Mar 2021
-
-$64.77M(-167.9%)
-$89.14M(-265.7%)
Dec 2020
-$24.38M(>-9900.0%)
-$24.18M(>-9900.0%)
-$24.38M(>-9900.0%)
Jun 2020
-
-$188.00K(-1988.9%)
-$197.00K(-2088.9%)
Mar 2020
-
-$9000.00
-$9000.00
Dec 2019
-$180.00K
-
-

FAQ

  • What is Edgewise Therapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. annual cash from investing year-on-year change?
  • What is Edgewise Therapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Edgewise Therapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Edgewise Therapeutics, Inc.?
  • What is Edgewise Therapeutics, Inc. TTM cash from investing year-on-year change?

What is Edgewise Therapeutics, Inc. annual cash from investing?

The current annual cash from investing of EWTX is -$184.66M

What is the all-time high annual cash from investing for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high annual cash from investing is $102.89M

What is Edgewise Therapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, EWTX annual cash from investing has changed by -$287.54M (-279.48%)

What is Edgewise Therapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of EWTX is -$162.17M

What is the all-time high quarterly cash from investing for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high quarterly cash from investing is $49.04M

What is Edgewise Therapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, EWTX quarterly cash from investing has changed by -$199.53M (-533.97%)

What is Edgewise Therapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of EWTX is -$71.98M

What is the all-time high TTM cash from investing for Edgewise Therapeutics, Inc.?

Edgewise Therapeutics, Inc. all-time high TTM cash from investing is $127.55M

What is Edgewise Therapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, EWTX TTM cash from investing has changed by +$108.55M (+60.13%)
On this page